会议专题

HPLC determination of irinotecan and its active metabolite SN-38 in human plasma

  Objective:To develop an HPLC method for the simultaneous determination ofirinotecan(CPT-11) and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) in human plasma.Methods:The internal standard was 10-hydroxycamptothecin.CPT-11 and SN-38 were extracted with ethyl acetate after a complete protein precipitation with 10% perchloric acid,then injected into a Hypersil C18(250 mm×4.6 mm,5um) column; The mobile phase was potassium dihydrogenphosphate (0.1mol·L-1)-acetonitrile (75∶25,adjusted pH3.0 with phosphoric acid);monitored at excitation and emission wavelengths of 355nm and 515nm,respectively.

HPLC irinotecan SN-38

ZHOU Wang PAN Ying LIAO Hai LIU Tao JIA ShouWei HUANG Hong-bing

Department of Pharmacy,Sun Yat-sen University Cancer Center,Guangzhou,510060

国内会议

2012医学科学前沿暨第二届个体化治疗与抗肿瘤药物研究新趋向研讨会

深圳

英文

447-447

2012-07-13(万方平台首次上网日期,不代表论文的发表时间)